June 23, 2023 – Federal Register Recent Federal Regulation Documents

Results 101 - 107 of 107
Inbound Competitive Multi-Service Agreements With Foreign Postal Operators
Document Number: 2023-13332
Type: Notice
Date: 2023-06-23
Agency: Postal Regulatory Commission, Agencies and Commissions
The Commission is recognizing a recent Postal Service filing of a change in certain modifications to the Competitive Multi-Product Agreements with Foreign Postal Operators 1 products to be effective July 1, 2023. This notice informs the public of the filing, invites public comment, and takes other administrative steps.
Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability
Document Number: 2023-13331
Type: Notice
Date: 2023-06-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act.'' This draft guidance provides recommendations for industry and review staff on the formal dispute resolution and administrative hearings procedures for resolving scientific and/or medical disputes between the Center for Drug Evaluation and Research (CDER) and requestors and sponsors of drugs that will be subject to a final administrative order (final order) under section 505G of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Advisory Committee; Medical Imaging Drugs Advisory Committee; Renewal
Document Number: 2023-13330
Type: Notice
Date: 2023-06-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the renewal of the Medical Imaging Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Medical Imaging Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the May 18, 2025, expiration date.
Vitagene, Inc.; Analysis of Proposed Consent Order To Aid Public Comment
Document Number: 2023-13329
Type: Notice
Date: 2023-06-23
Agency: Federal Trade Commission, Agencies and Commissions
The consent agreement in this matter settles alleged violations of Federal law prohibiting unfair or deceptive acts or practices. The attached Analysis of Proposed Consent Order to Aid Public Comment describes both the allegations in the complaint and the terms of the consent orderembodied in the consent agreementthat would settle these allegations.
Agency Information Collection Activities: Comment Request
Document Number: 2023-13326
Type: Notice
Date: 2023-06-23
In accordance with the Paperwork Reduction Act of 1995 (PRA), the Consumer Financial Protection Bureau (Bureau or CFPB) requests the extension of the Office of Management and Budget's (OMB's) approval for an existing information collection titled ``Payday, Vehicle Title, and Certain High-Cost Installment Loans,'' approved under OMB Control Number 3170-0071.
Agency Information Collection Activities: Comment Request
Document Number: 2023-13325
Type: Notice
Date: 2023-06-23
In accordance with the Paperwork Reduction Act of 1995 (PRA), the Consumer Financial Protection Bureau (Bureau or CFPB) requests the extension of the Office of Management and Budget's (OMB's) approval for an existing information collection titled ``Consumer Response Company Response Survey,'' approved under OMB Number 3170-0069.
National Institute on Minority Health and Health Disparities; Notice of Meeting
Document Number: 2023-13324
Type: Notice
Date: 2023-06-23
Agency: Department of Health and Human Services, National Institutes of Health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.